TrialRadiation oncology (London, England)2016

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.

Fiorenza De Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.